247 related articles for article (PubMed ID: 27154175)
1. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis.
Shen X; Wang J; Yan X; Ren X; Wang F; Chen X; Xu Y
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1285-302. PubMed ID: 27154175
[TBL] [Abstract][Full Text] [Related]
2. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Kong X; Li Z; Li X
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
[TBL] [Abstract][Full Text] [Related]
3. Associations of the glutathione S-transferase P1 Ile105Val genetic polymorphism with gynecological cancer susceptibility: a meta-analysis.
Zhao E; Hu K; Zhao Y
Oncotarget; 2017 Jun; 8(25):41734-41739. PubMed ID: 28410197
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
Wang Z; Xue L; Chong T; Li H; Chen H; Wang Z
Tumour Biol; 2013 Jun; 34(3):1651-7. PubMed ID: 23483487
[TBL] [Abstract][Full Text] [Related]
5. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
Zhao R; Chen G
Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821
[TBL] [Abstract][Full Text] [Related]
6. Association of glutathione S-transferase pi (GSTP1) Ile105Val polymorphism with the risk of skin cancer: a meta-analysis.
Zhou CF; Ma T; Zhou DC; Shen T; Zhu QX
Arch Dermatol Res; 2015 Aug; 307(6):505-13. PubMed ID: 26044055
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients.
Kweekel DM; Gelderblom H; Antonini NF; Van der Straaten T; Nortier JW; Punt CJ; Guchelaar HJ
Eur J Cancer; 2009 Mar; 45(4):572-8. PubMed ID: 19084393
[TBL] [Abstract][Full Text] [Related]
8. GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.
Kweekel DM; Koopman M; Antonini NF; Van der Straaten T; Nortier JW; Gelderblom H; Punt CJ; Guchelaar HJ
Br J Cancer; 2008 Oct; 99(8):1316-21. PubMed ID: 18797455
[TBL] [Abstract][Full Text] [Related]
9. X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
Wu H; Xu C; Chen G; Wang J
J Gastroenterol Hepatol; 2014 May; 29(5):926-33. PubMed ID: 24224851
[TBL] [Abstract][Full Text] [Related]
10. Association Analysis of GSTP1-rs1695 Polymorphism with the Risk of Oral Cancer: A Literature Review, an Updated Meta- Analysis, and a Structural Assessment.
Baghaei A; Behjati M; Karimian A
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3859-3868. PubMed ID: 36444599
[TBL] [Abstract][Full Text] [Related]
11. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.
Zhao ZQ; Guan QK; Yang FY; Zhao P; Zhou B; Chen ZJ
Tumour Biol; 2012 Apr; 33(2):523-35. PubMed ID: 22161138
[TBL] [Abstract][Full Text] [Related]
12. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies.
Song Y; Chen J; Liu K; Zhou K; Lu Y; Wang X; Yang Y; Liu X
Gene; 2019 Nov; 719():144077. PubMed ID: 31454540
[TBL] [Abstract][Full Text] [Related]
14. Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.
Yu Z; Li Z; Cai B; Wang Z; Gan W; Chen H; Li H; Zhang P; Li H
Tumour Biol; 2013 Jun; 34(3):1855-63. PubMed ID: 23494181
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.
Zarate R; Rodríguez J; Bandres E; Patiño-Garcia A; Ponz-Sarvise M; Viudez A; Ramirez N; Bitarte N; Chopitea A; Gacía-Foncillas J
Br J Cancer; 2010 Mar; 102(6):987-94. PubMed ID: 20216541
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy.
Yokomizo A; Yamamoto K; Kinukawa N; Tsunoda T; Koga H; Naito S
Int J Urol; 2007 Jun; 14(6):500-4. PubMed ID: 17593093
[TBL] [Abstract][Full Text] [Related]
17. Association between the GSTP1 codon 105 polymorphism and gastric cancer risk: an updated meta-analysis.
Bao LD; Niu JX; Song H; Wang Y; Ma RL; Ren XH; Wu XL
Asian Pac J Cancer Prev; 2012; 13(8):3687-93. PubMed ID: 23098455
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy.
Liu YP; Ling Y; Qi QF; Zhang YP; Zhang CS; Zhu CT; Wang MH; Pan YD
Mol Med Rep; 2013 Jun; 7(6):1904-11. PubMed ID: 23604281
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population.
Chen X; Liang L; Hu X; Chen Y
Tumour Biol; 2012 Dec; 33(6):1973-81. PubMed ID: 22797821
[TBL] [Abstract][Full Text] [Related]
20. Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.
Chen YC; Tzeng CH; Chen PM; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
Cancer Sci; 2010 Feb; 101(2):530-5. PubMed ID: 19922504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
